Condensed Statement of Shareholders' Deficiency - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)			1,233,853
Beginning Balance	$ (785,812)	$ (716,824)	$ (745,020)	$ (678,551)
Net loss	$ (19,781)	(89)	$ (60,573)	(38,362)
Ending Balance (in shares)	1,233,853		1,233,853
Ending Balance	$ (805,593)	$ (716,913)	$ (805,593)	$ (716,913)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Beginning Balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Ending Balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Ending Balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	81,323	81,323	81,323	81,323
Ending Balance	81,323	81,323	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(868,368)	(799,380)	(827,576)	(761,107)
Net loss	(19,781)	(89)	(60,573)	(38,362)
Ending Balance	$ (888,149)	$ (799,469)	$ (888,149)	$ (799,469)